ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryLiestalCuratis AG
Curatis AG Logo
Verified· 3 sources

Curatis AG

Summary

About the company

Curatis AG is a specialty pharmaceutical company focused on acquiring, developing and commercialising medicines for the prevention, diagnosis and treatment of rare and specialty‑care diseases. The company operates a distribution business for third‑party orphan and specialty medicines and a development business advancing proprietary drug candidates (e.g., C‑PTBE‑01, C‑AM‑01, C‑MOH‑01, C‑FI‑01) toward clinical development.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Distribution and commercialization of specialty and orphan medicines
Acquisition, licensing, distribution and marketing of medicines for rare and specialty diseases in Switzerland; exclusive distribution rights for numerous products and international partner medicines.
Development of orphan and specialty-care medicines
Development of new specialty and orphan drugs with existing safety and efficacy data; pipeline projects in preclinical and clinical development for rare diseases and conditions with specific care needs.
Commercial partnerships for Switzerland
Tailored partner packages for the commercialization of pharmaceutical products in Switzerland, including market access, registration, pricing, reimbursement, marketing, sales, early-access programmes and pharmacovigilance.
Partnerships for the development of new medicines
Co-development and licensing models for late-stage clinical development projects with biotech, pharma and contract research and manufacturing organizations.
Medicines portfolio
Portfolio of medicines marketed and distributed in Switzerland for pain, oncology, urology, endocrinology, ophthalmology, infectiology, neurology and other therapeutic specialties.
Press

Media

June 30, 2026Media
Curatis erhöht Umsatzwachstumsprognose für 2026
cash.ch
March 24, 2026Media
Curatis steigert Umsatz deutlich und will 2026 schwarze Zahlen schreiben
cash.ch
April 26, 2024Media
Kinarus heisst ab sofort Curatis
fuw.ch

Knowledge

No knowledge articles yet

Once Curatis AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Curatis AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Curatis AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Curatis AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Weierweg 7
4410 Liestal

At a glance

Legal form
Corporation
UID
CHE-108.721.090
Founded
1993 · 33 years
Last commercial register change
June 3, 2026
Employees
21 to 50

Similar companies

WA
Weleda AG
Arlesheim
TP
T3 Pharmaceuticals AG
Allschwil
MP
Merz Pharma (Schweiz) AG
Allschwil
NP
Novartis Pharma Schweizerhalle AG
Pratteln